Investigational OCTA Devices Show Promise in Diabetic Disease Assessment - Top_Thought_Leaders - MDSpire

Investigational OCTA Devices Show Promise in Diabetic Disease Assessment

At Retina World Congress, Patricio G. Schlottmann, MD, discussed investigational widefield OCTA platforms made by Chinese company TowardPi Medical.

Share

Brief introduction explaining scope and methodology.

Retinal Physician

Conexiant

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort

The Ophthalmologist

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

Bmc Ophthalmology